Comparison of Single-Treatment Efficacy of Bevacizumab and Ranibizumab for Retinopathy of Prematurity
Background: Retinopathy of prematurity (ROP) is a significant cause of blindness in infants. Appropriate therapeutic intervention is essential because retinal detachment due to the progression of ROP is critical to visual function. The intravitreal injection of anti-vascular endothelial growth facto...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2024-07-01
|
| Серии: | Children |
| Предметы: | |
| Online-ссылка: | https://www.mdpi.com/2227-9067/11/8/927 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|